Overview

Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mg

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the bioequivalence between two oral nicotine sublingual tablets, 2 mg and 4 mg.
Phase:
N/A
Details
Lead Sponsor:
McNeil AB
Treatments:
Nicotine